日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and Safety of Upadacitinib versus Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Four Body Regions: Analysis from the Heads Up Study

乌帕替尼与度普利尤单抗治疗中重度特应性皮炎在四个身体区域的疗效和安全性比较：来自 HEAD UP 研究的分析

期刊:Dermatology
影响因子:2.7
doi:10.1159/000542275
Thyssen, Jacob P; Rosmarin, David; Costanzo, Antonio; Warren, Richard; Chu, Chia-Yu; Chovatiya, Raj; Ladizinski, Barry; Hu, Xiaofei; Liu, Yingyi; Calimlim, Brian; Nduaka, Chudi; Vigna, Namita; Armstrong, April
发表日期：2025
文献求助 收藏

Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)

Upadacitinib 可快速改善特应性皮炎患者报告的结局：3 期临床试验（Measure Up 1 和 2）的 16 周结果

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-024-01157-5
Simpson, Eric L; Prajapati, Vimal H; Leshem, Yael A; Chovatiya, Raj; de Bruin-Weller, Marjolein S; Ständer, Sonja; Pink, Andrew E; Calimlim, Brian M; Lee, Wan-Ju; Teixeira, Henrique; Ladizinski, Barry; Hu, Xiaofei; Yang, Yang; Liu, Yingyi; Liu, Meng; Grada, Ayman; Platt, Andrew M; Silverberg, Jonathan I
发表日期：2024
文献求助 收藏

Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials

乌帕替尼治疗中重度特应性皮炎青少年患者的疗效和安全性：Measure Up 1、Measure Up 2 和 AD Up 随机临床试验分析

期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2023.0391
Paller, Amy S; Ladizinski, Barry; Mendes-Bastos, Pedro; Siegfried, Elaine; Soong, Weily; Prajapati, Vimal H; Lio, Peter; Thyssen, Jacob P; Simpson, Eric L; Platt, Andrew M; Raymundo, Eliza M; Liu, Jianzhong; Calimlim, Brian M; Huang, Xiaohong; Gu, Yihua; Hu, Xiaofei; Yang, Yang; Su, John C; Zheng, Min; Yamamoto-Hanada, Kiwako; Teixeira, Henrique D; Irvine, Alan D
发表日期：2023
文献求助 收藏

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial

乌帕替尼与度普利尤单抗治疗中重度特应性皮炎成人患者的疗效和安全性：一项随机临床试验

期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2021.3023
Blauvelt, Andrew; Teixeira, Henrique D; Simpson, Eric L; Costanzo, Antonio; De Bruin-Weller, Marjolein; Barbarot, Sebastien; Prajapati, Vimal H; Lio, Peter; Hu, Xiaofei; Wu, Tianshuang; Liu, John; Ladizinski, Barry; Chu, Alvina D; Eyerich, Kilian
发表日期：2021
文献求助 收藏

Calcinosis in adult-onset dermatomyositis: metastatic or dystrophic?

成人发病型皮肌炎中的钙质沉积：转移性还是营养不良性？

期刊:Journal of General Internal Medicine
影响因子:4.2
doi:10.1007/s11606-013-2564-4
Ladizinski, Barry; Khan, Ali; Sankey, Christopher
发表日期：2014
文献求助 收藏

Aortic graft infection

主动脉移植物感染

期刊:Journal of General Internal Medicine
影响因子:4.2
doi:10.1007/s11606-014-2838-5
Ladizinski, Barry; Sankey, Christopher
炎症/感染
发表日期：2014
文献求助 收藏

Bullous pemphigoid

大疱性类天疱疮

期刊:Journal of General Internal Medicine
影响因子:4.2
doi:10.1007/s11606-012-2250-y
Ladizinski, Barry; Lee, Kachiu Cecelia
发表日期：2013
文献求助 收藏

Indoor tanning amongst young adults: time to stop sleeping on the banning of sunbeds

年轻人室内日光浴：是时候停止对日光浴床禁令的漠视了

期刊:Journal of General Internal Medicine
影响因子:4.2
doi:10.1007/s11606-013-2552-8
Ladizinski, Barry; Lee, Kachiu C; Ladizinski, Renata; Federman, Daniel G
发表日期：2013
文献求助 收藏

Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge

使用左旋咪唑污染的可卡因引发的并发症：一项新出现的公共卫生挑战

期刊:Mayo Clinic Proceedings
影响因子:6.7
doi:10.1016/j.mayocp.2012.03.010
Lee, Kachiu C; Ladizinski, Barry; Federman, Daniel G
发表日期：2012
文献求助 收藏